News

A recent study linked cancer cell shapes to gene expression.

Glass developer X has announced a pivot toward industry, with healthcare being an emphasis.

The App Wrap focuses on a select few health apps that strive to make a meaningful difference for healthcare providers and their patients.

The study showed that Watson could produce actionable clinical data in 10 minutes that would ordinarily take humans 160 hours.

The hospital will now offer a telehealth service for pediatric patients.

The research organization is introducing a population of sterile mosquitos in California to curtail disease.

Japanese researchers have developed a nanomesh for wearable health monitoring that they say can be worn for a week without discomfort.

In Part 2 of the interview, Bradley speaks to what makes analytics in healthcare unique, the breadth and integrity of provider data, and how better financial interactions with patients may improve their perception of healthcare providers

The life science research organization will use its wearable, Study Watch, to work with UNC and Harvard on the expansive mental health study.

“All of the goodwill that’s been accumulated when we have the patient in our care, that’s thrown out the window because we haven’t maintained the patient experience in the financial relationship we have with the patient.”

In the face of mosquito-borne threats like Zika, Microsoft joins other tech firms in trying to combat the flying vectors.

"Two years ago people were still saying 'well, let’s see what happens to these programs.' Now, everyone is saying that it isn’t a question of 'if', it’s 'at what pace?'"

The announcement continues a trend of technology companies, app makers, and glucose monitor makers pairing up to create integrated care systems.

"Sometimes serendipity smiles." Dr. Drouin, in the first part of our interview, spoke to the needs his company aims to fill, the pursuit of value-based care, and the process of leaving a career and getting a startup off the ground.

The company is expanding its digital health platform in partnership with IBM Watson Health.

“Big data is not just about big numbers, but also the patterns that can explain important health trends,” says the NIH's Grace Peng. A new Stanford study used some huge data to track obesity.

Value-based care is not necessarily cheap. A new MIT study finds that hospitals more reliant on outpatient nursing facilities often yield higher mortality rates.

Wearables just might not have the appeal and sustainability once thought, if the fall of one of the market’s earliest stars is any indication. Today, it was reported that Jawbone was liquidating itself.

In published documents and a detailed blog post from its Commissioner, the FDA made public its plans for using data modelling to improve regulatory trials.

Many healthcare product companies continue to downplay the potential impact that investments in data analytics could have on their business.

Electronic health records are the equivalent of “texting at the dinner table.” That opinion was common among a group of physicians studied by Brown University researchers.

Keeping young patients with long-term health concerns engaged via text, email, and phone calls might improve outcomes and reduce healthcare costs down the road. On that road, however, there are plenty of challenges to consider.

The company's DeepMind subsidiary and the UK's Royal Free health system may not have done enough to inform patients their data was in use. The two are working to develop an alert application to analyze risk of kidney disease.

The UN has released its annual report on global cybersecurity. The report aims to measure which countries are most committed to making the web more secure, scoring countries according to five pillars: technical, organizational, legal, cooperation and growth potential.

The FDA first authorized the use of Dignicap in April to thwart chemo-related hair loss in patients undergoing chemotherapy for breast cancer. The agency has now expanded the cap’s use to include patients with all types of solid tumors. The device circulates cool liquid to minimize the effects of chemo drugs on hair follicles.

The acquisition positions Roche to enhance interoperability and integration with its Accu-Chek line of blood glucose monitors.

"Whether such artificial-intelligence systems are ‘smarter’ than human practitioners makes for a stimulating debate—but is largely irrelevant," they write.

The recent attack ravaged everything from Maersk to Merck. It also impacted small health systems in the US, whether it meant to or not.